For research use only. Not for therapeutic Use.
TNG-0746132（Cat No.:I041281）is an experimental small molecule compound under investigation for its potential therapeutic applications. It has shown promise in preclinical studies as a selective inhibitor targeting specific enzymes or signaling pathways involved in disease processes. The compound has been explored primarily in the context of cancer and inflammation, aiming to block key molecular interactions that drive tumor growth or inflammatory responses. Research on TNG-0746132 is ongoing, with the goal of developing it into a novel treatment option for cancer and inflammatory disorders by selectively modulating relevant biological targets.
| CAS Number | 2821749-57-7 |
| Synonyms | 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-7-[[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine |
| Molecular Formula | C26H22F3N7O |
| Purity | ≥95% |
| IUPAC Name | 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-7-[[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidine |
| InChI | InChI=1S/C26H22F3N7O/c1-36-12-19(26(27,28)29)34-24(36)16-5-3-14(4-6-16)9-17-10-30-18-11-31-23(35-21(17)18)20-22(15-7-8-15)32-13-33-25(20)37-2/h3-6,10-13,15,30H,7-9H2,1-2H3 |
| InChIKey | ONJHDRGRJAZAHT-UHFFFAOYSA-N |
| SMILES | CN1C=C(N=C1C2=CC=C(C=C2)CC3=CNC4=CN=C(N=C34)C5=C(N=CN=C5OC)C6CC6)C(F)(F)F |
